| Secondary |
| Drug Use For Unknown Indication |
34.9% |
| Gout |
11.6% |
| Hypertension |
9.3% |
| Pharyngitis |
9.3% |
| Atrial Fibrillation |
7.0% |
| Arrhythmia |
4.7% |
| Cardiac Failure Congestive |
4.7% |
| Odynophagia |
4.7% |
| Pain |
4.7% |
| Pneumonia |
4.7% |
| Essential Hypertension |
2.3% |
| Hypokalaemia |
2.3% |
|
| Stevens-johnson Syndrome |
22.2% |
| Testicular Oedema |
22.2% |
| Deep Vein Thrombosis |
11.1% |
| Eye Haemorrhage |
11.1% |
| Oliguria |
11.1% |
| Renal Failure Acute |
11.1% |
| Somnolence |
11.1% |
|
| Concomitant |
| Hypertension |
15.3% |
| Drug Use For Unknown Indication |
14.0% |
| Diffuse Large B-cell Lymphoma |
8.8% |
| Rheumatoid Arthritis |
6.9% |
| Prophylaxis |
5.9% |
| Gout |
5.6% |
| Atrial Fibrillation |
4.6% |
| Type 2 Diabetes Mellitus |
4.4% |
| Product Used For Unknown Indication |
4.0% |
| Chronic Lymphocytic Leukaemia |
3.6% |
| Diabetes Mellitus |
3.6% |
| Renal Transplant |
3.6% |
| Stem Cell Transplant |
3.1% |
| Pain |
2.9% |
| Osteoporosis |
2.7% |
| Pulmonary Fibrosis |
2.7% |
| Chronic Obstructive Pulmonary Disease |
2.5% |
| Viral Test Positive |
2.1% |
| Hyperuricaemia |
1.9% |
| Tachycardia |
1.9% |
|
| Transient Ischaemic Attack |
20.0% |
| Renal Failure Acute |
10.0% |
| Viral Test Positive |
7.5% |
| Hepatic Function Abnormal |
5.0% |
| Respiratory Failure |
5.0% |
| Vomiting |
5.0% |
| Electrocardiogram Qt Prolonged |
3.8% |
| Proteinuria |
3.8% |
| Pyrexia |
3.8% |
| Septic Shock |
3.8% |
| Stomatitis |
3.8% |
| Therapeutic Agent Toxicity |
3.8% |
| Traumatic Brain Injury |
3.8% |
| Urinary Retention |
3.8% |
| Urinary Tract Infection |
3.8% |
| Wheezing |
3.8% |
| Breast Lump Removal |
2.5% |
| Cardiac Arrest |
2.5% |
| Clostridium Difficile Colitis |
2.5% |
| Death |
2.5% |
|
| Interacting |
| Arrhythmia |
33.3% |
| Cardiac Failure Congestive |
33.3% |
| Gout |
16.7% |
| Hypokalaemia |
16.7% |
|
| Renal Failure Acute |
100.0% |
|
